Taking 52 injections per year versus 365 creates less daily burden, fewer opportunities to forget doses, and easier integration into lifestyle
This significantly reduces effort and improves consistency for all users, especially those with busy lifestyles
Last week, podcast host Andrew Huberman highlighted Retatrutide, a powerful new weight loss drug, posting, retatrutide is a real challenge to those that liked to bash on other GLP-1 agonists, etc., because its used by (soon) everyone. Retatrutide is the ultimate good, said looksmaxxing influencer Braden Peters, a.k.a
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults
In research models this produces a larger, cleaner GH pulse than either compound alone
Safety, Regulation, and Quality Considerations The U.S